Mereo BioPharma (MREO) Interest Coverage Ratio (2023 - 2026)
Mereo BioPharma (MREO) posted quarterly Interest Coverage Ratio of 42.55 for Q1 2026, up 27.06% year-over-year from 33.49 in Q1 2025, and up 88.33% quarter-over-quarter from 364.78 in Q4 2025.
Mereo BioPharma (MREO) Interest Coverage Ratio (2023 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has reported Interest Coverage Ratio for 4 consecutive years, with 42.55 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 27.06% year-over-year to 42.55; the TTM figure through Mar 2026 stood at 42.28 (down 22.85% YoY), while the FY2025 annual figure was 0.18, up 19.71% from the prior year.
- Interest Coverage Ratio rose to 42.55 in Q1 2026 per MREO's latest filing, from 364.78 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 0.39 in Q3 2024 and bottomed at 364.78 in Q4 2025.
- Historically, Interest Coverage Ratio has averaged 44.49 across 4 years, with a median of 14.26 in 2023.
- Annual changes were most pronounced in 2024 — Interest Coverage Ratio surged 96.97% — and 2025, when it sank 1022.41%.
- Mereo BioPharma's Interest Coverage Ratio stood at 16.13 in 2023, then plunged by 101.53% to 32.5 in 2024, then tumbled by 1022.41% to 364.78 in 2025, then soared by 88.33% to 42.55 in 2026.
- Business Quant data shows MREO's Interest Coverage Ratio at 42.55 in Q1 2026, 364.78 in Q4 2025, and 2.07 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Mereo BioPharma | 47.39 Mn | 47.39 Mn | - | -439.38 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.54 |
| Mar 31, 2026 | -42.55 |
| Dec 31, 2025 | -364.78 |
| Sep 30, 2025 | -2.07 |
| Jun 30, 2025 | -1.04 |
| Mar 31, 2025 | -58.34 |
| Dec 31, 2024 | -32.50 |
| Sep 30, 2024 | -0.39 |
| Jun 30, 2024 | -0.68 |
| Mar 31, 2024 | -31.94 |
| Dec 31, 2023 | -16.13 |
| Sep 30, 2023 | -12.95 |
| Jun 30, 2023 | -0.79 |
| Mar 31, 2023 | -14.26 |